Warning about insulin pump failure 18 August 2025 Users of the t:slim X2 insulin pump are being made aware of a malfunction that could stop the device from working. The Therapeutic Goods Administration (TGA) has issued a warning that certain versions of the insulin pump have a wiring problem with the speaker that could stop the delivery of insulin. Australasian Medical and Scientific Ltd (AMSL) alerted the TGA to the failure which appears on device screens as Malfunction Code 16-0x20E6, or simply ‘Malfunction 16’. ARTG numberCatalogue numberMultiple serial numbers30468110027175317 unique serial numbers identified in Australia What are the risks? The problem could: Stop insulin delivery and disconnect the pump from the Continuous Glucose Monitoring (CGM) and mobile app. Lead to hyperglycaemia if not addressed promptly. Require patients to seek medical intervention or hospitalisation in serious cases. Result in loss of real-time glucose data and trends. What should I do? If Malfunction 16 has not occurred: Continue using your pump as per the user guide. Install the Tandem t:slim mobile app and enable push notifications. This ensures that if the problem does occur, you will be notified by the app. If using a Dexcom sensor, use the Dexcom mobile app as a backup source for CGM alerts and alarms. If a Malfunction 16 occurs: Acknowledge the alert by pressing “Silence Alarm.” Contact AMSL Technical Support at 1300 851 056, who will arrange for a replacement pump. In the meantime, switch to your backup insulin delivery method. You should continue to monitor your blood glucose levels regularly and ensure a backup insulin method is available as per the pump training and user guide. Further information Please contact AMSL on 1300 851 056 for further information. A software update is in development that will improve early detection of speaker failure and introduce persistent vibration alerts. Pump users will be notified when this software update becomes available. Reporting problems Consumers and health professionals are encouraged to report problems with medical devices. Your report will contribute to our monitoring of these products. For more information see the TGA Incident Reporting and Investigation Scheme (IRIS). The TGA cannot give advice about an individual’s medical condition. You are strongly encouraged to talk with a health professional if you are concerned about a possible adverse event associated with a medical device.
Blog 27 July 2026 Round up for Diabetes Australia and turn small change into impact Learn how your spare change with Round up goes straight to Diabetes Australia to support programs, research, education, and advocacy. Continue Reading
News 24 July 2026 GLP-1 RA safety update for rare but severe eye disorders The Therapeutic Goods Administration has updated GLP-1 RA product warnings because of their potential to cause a rare but severe eye disorder. The glucagon-like peptide-1 receptor agonist... Continue Reading
Blog 22 July 2026 Living Out Loud: how Australia spoke up for National Diabetes Week 2026 From 12 to 18 July, Australians living with diabetes, alongside their carers, researchers, health professionals and clinicians, did something powerful. They... Continue Reading